Dual inhibition of CDK4/6 and IL-6 pathways as a novel therapeutic approach for triple-negative breast cancer cells

被引：0
|
作者：
Caroland, Kailey
Shi, Changyou
Lo, Hui-Wen
Lin, Jiayuh
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4610
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4610
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Combined CDK4/6 and PI3Kα Inhibition Is Synergistic and Immunogenic in Triple-Negative Breast Cancer
    Teo, Zhi Ling
    Versaci, Stephanie
    Dushyanthen, Sathana
    Caramia, Franco
    Savas, Peter
    Mintoff, Chris P.
    Zethoven, Magnus
    Virassamy, Balaji
    Luen, Stephen J.
    McArthur, Grant A.
    Phillips, Wayne A.
    Darcy, Phillip K.
    Loi, Sherene
    CANCER RESEARCH, 2017, 77 (22) : 6340 - 6352
  • [22] Efficacy and mechanism of the combination of PARP and CDK4/6 inhibitors in the treatment of triple-negative breast cancer
    Zhu, Xiuzhi
    Chen, Li
    Huang, Binhao
    Li, Xiaoguang
    Yang, Liu
    Hu, Xin
    Jiang, Yizhou
    Shao, Zhimin
    Wang, Zhonghua
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [23] Efficacy and mechanism of the combination of PARP and CDK4/6 inhibitors in the treatment of triple-negative breast cancer
    Xiuzhi Zhu
    Li Chen
    Binhao Huang
    Xiaoguang Li
    Liu Yang
    Xin Hu
    Yizhou Jiang
    Zhimin Shao
    Zhonghua Wang
    Journal of Experimental & Clinical Cancer Research, 40
  • [24] Inhibition of ACAA1 Restrains Proliferation and Potentiates the Response to CDK4/6 Inhibitors in Triple-Negative Breast Cancer
    Peng, Wen -Ting
    Jin, Xi
    Xu, Xiao-En
    Yang, Yun-Song
    Ma, Ding
    Shao, Zhi-Ming
    Jiang, Yi-Zhou
    CANCER RESEARCH, 2023, 83 (10) : 1711 - 1724
  • [25] Identification of subtypes of triple negative breast cancer (TNBC) that are sensitive to CDK4/6 inhibition.
    Asghar, Uzma
    Herrera-Abreu, Maria Teresa
    Cutts, Ros
    Babina, Irina
    Pearson, Alex
    Turner, Nicholas C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [26] The Role of CDK4/6 Inhibition in Breast Cancer
    Murphy, Conleth G.
    Dickler, Maura N.
    ONCOLOGIST, 2015, 20 (05): : 483 - U49
  • [27] CDK4/6 inhibition in luminal breast cancer
    Gampenrieder S.P.
    Rinnerthaler G.
    Greil R.
    memo - Magazine of European Medical Oncology, 2016, 9 (2) : 76 - 81
  • [28] Palbociclib, a CDK4/6 inhibitor, suppresses proliferation of triple negative breast cancer
    Min, Ahrum
    Kim, Yu Jin
    Hang, Hyemin
    Lim, Jee Min
    Kim, Seongyeong
    Kim, So Hyeon
    Suh, Koung Jin
    Lee, Kyung-Hun
    Kim, Tae-Yong
    Im, Seock-Ah
    CANCER RESEARCH, 2018, 78 (13)
  • [29] Combination of CDK4/6 inhibitors with biguanides for treatment of triple negative breast cancer
    Martinez, Mario Morales
    Gonzalez, Eduardo Mauricio
    Deng, Gang
    Ma, Gaoyuan
    Kim, Hyunsoo
    Stiles, Linsey
    Hamilton, Nalo
    Jung, Michael E.
    Pietras, Richard J.
    Marquez-Garban, Diana C.
    CANCER RESEARCH, 2024, 84 (06)
  • [30] Investigating anti-tumor immunity with CDK4/6 inhibition in triple negative breast cancer.
    Guo, Qiuchen
    Spasic, Milos
    Goreczny, Gregory
    Maynard, Adam
    McAllister, Sandra
    CANCER RESEARCH, 2021, 81 (13)
12345